Literature DB >> 21865649

Uroguanylin: how the gut got another satiety hormone.

Randy J Seeley1, Matthias H Tschöp.   

Abstract

Prouroguanylin is a gastrointestinal paracrine signal and prohormone that is secreted after nutrient ingestion. In this issue of the JCI, Valentino et al. show that prouroguanylin is converted to uroguanylin in the CNS, which can activate guanylyl cyclase 2C (GUCY2C) receptors in the brain to reduce food intake in mice. This 16-amino acid residue peptide is a novel component of the gut-brain axis that represents a new and unique opportunity to manipulate gut-brain signaling for therapeutic intervention in obesity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865649      PMCID: PMC3163973          DOI: 10.1172/JCI58297

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Insulin, cGMP, and TGF-beta signals regulate food intake and quiescence in C. elegans: a model for satiety.

Authors:  Young-jai You; Jeongho Kim; David M Raizen; Leon Avery
Journal:  Cell Metab       Date:  2008-03       Impact factor: 27.287

2.  A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.

Authors:  Michael A Valentino; Jieru E Lin; Adam E Snook; Peng Li; Gilbert W Kim; Glen Marszalowicz; Michael S Magee; Terry Hyslop; Stephanie Schulz; Scott A Waldman
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

Review 3.  Renal electrolyte effects of guanylin and uroguanylin.

Authors:  Aleksandra Sindić; Eberhard Schlatter
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-01       Impact factor: 2.894

4.  Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake.

Authors:  Jian V Zhang; Pei-Gen Ren; Orna Avsian-Kretchmer; Ching-Wei Luo; Rami Rauch; Cynthia Klein; Aaron J W Hsueh
Journal:  Science       Date:  2005-11-11       Impact factor: 47.728

5.  The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness.

Authors:  Kimberly P Kinzig; David A D'Alessio; Randy J Seeley
Journal:  J Neurosci       Date:  2002-12-01       Impact factor: 6.167

Review 6.  Gastrointestinal hormones and food intake.

Authors:  April D Strader; Stephen C Woods
Journal:  Gastroenterology       Date:  2005-01       Impact factor: 22.682

Review 7.  Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics.

Authors:  Leonard Ralph Forte
Journal:  Pharmacol Ther       Date:  2004-11       Impact factor: 12.310

8.  Ghrelin's Roles in Stress, Mood, and Anxiety Regulation.

Authors:  Jen-Chieh Chuang; Jeffrey M Zigman
Journal:  Int J Pept       Date:  2010-02-14

Review 9.  Gut and hormones and obesity.

Authors:  Alison M Wren
Journal:  Front Horm Res       Date:  2008       Impact factor: 2.606

10.  The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress.

Authors:  Michael Lutter; Ichiro Sakata; Sherri Osborne-Lawrence; Sherry A Rovinsky; Jason G Anderson; Saendy Jung; Shari Birnbaum; Masashi Yanagisawa; Joel K Elmquist; Eric J Nestler; Jeffrey M Zigman
Journal:  Nat Neurosci       Date:  2008-06-15       Impact factor: 24.884

View more
  10 in total

1.  Guanylin and uroguanylin stimulate lipolysis in human visceral adipocytes.

Authors:  A Rodríguez; J Gómez-Ambrosi; V Catalán; S Ezquerro; L Méndez-Giménez; S Becerril; P Ibáñez; N Vila; M A Margall; R Moncada; V Valentí; C Silva; J Salvador; G Frühbeck
Journal:  Int J Obes (Lond)       Date:  2016-04-25       Impact factor: 5.095

2.  Immunohistochemical Staining for Uroguanylin, a Satiety Hormone, is Decreased in Intestinal Tissue Specimens From Female Adolescents With Obesity.

Authors:  Matthew D Di Guglielmo; Lacey Perdue; Adebowale Adeyemi; Kenneth L van Golen; Diana U Corao
Journal:  Pediatr Dev Pathol       Date:  2017-08-29

3.  Two distinct GUCY2C circuits with PMV (hypothalamic) and SN/VTA (midbrain) origin.

Authors:  D J Merlino; J R Barton; B A Charsar; M D Byrne; J A Rappaport; R J Smeyne; A C Lepore; A E Snook; S A Waldman
Journal:  Brain Struct Funct       Date:  2019-09-04       Impact factor: 3.270

4.  Uroguanylin levels in intestine and plasma are regulated by nutritional status in a leptin-dependent manner.

Authors:  C Folgueira; E Sanchez-Rebordelo; S Barja-Fernandez; R Leis; S Tovar; F F Casanueva; C Dieguez; R Nogueiras; L M Seoane
Journal:  Eur J Nutr       Date:  2015-03-06       Impact factor: 5.614

5.  Pilot Study Measuring the Novel Satiety Hormone, Pro-Uroguanylin, in Adolescents With and Without Obesity.

Authors:  Matthew D Di Guglielmo; Dalal Tonb; Zhaoping He; Adebowale Adeyemi; Kenneth L van Golen
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-03       Impact factor: 2.839

Review 6.  Pendrin, a novel transcriptional target of the uroguanylin system.

Authors:  Julia Rozenfeld; Osnat Tal; Orly Kladnitsky; Lior Adler; Edna Efrati; Stephen L Carrithers; Seth L Alper; Israel Zelikovic
Journal:  Cell Physiol Biochem       Date:  2013-12-18

7.  The receptor guanylyl cyclase type D (GC-D) ligand uroguanylin promotes the acquisition of food preferences in mice.

Authors:  Hiroyuki Arakawa; Kevin R Kelliher; Frank Zufall; Steven D Munger
Journal:  Chem Senses       Date:  2013-04-04       Impact factor: 3.160

Review 8.  Natriuretic hormones in brain function.

Authors:  Anastasia Hodes; David Lichtstein
Journal:  Front Endocrinol (Lausanne)       Date:  2014-11-28       Impact factor: 5.555

9.  Circulating Pro-Uroguanylin Levels In Children And Their Relation To Obesity, Sex And Puberty.

Authors:  Cintia Folgueira; Silvia Barja-Fernández; Patricia Gonzalez-Saenz; Cecilia Castelao; Rocío Vázquez-Cobela; Veronica Pena-Leon; Manuel Ruiz-Piñon; Felipe F Casanueva; Carlos Dieguez; Rosaura Leis; Rubén Nogueiras; Luisa M Seoane
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

Review 10.  Guanylyl cyclase C signaling axis and colon cancer prevention.

Authors:  Amanda M Pattison; Dante J Merlino; Erik S Blomain; Scott A Waldman
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.